Skip to main content

Table 4 Linear regression analyses of the five components of MetS and depression (N = 14.148–14.496 a)

From: Associations between degree and sub-dimensions of depression and metabolic syndrome (MetS) in the community: results from the Gutenberg Health Study (GHS)

  

Depressive symptoms (PHQ)

Somatic-affective symptoms

Cognitive-affective symptoms

  

B (95% CI)

B (95% CI)

B (95% CI)

Model 1

High triglycerides

Low HDL

Hypertension

Central obesity

High fasting blood glucose

0.020 (0.007/ 0.034); p = .003

0.050 (0.036/ 0.065); p < .001

−0.028 (− 0.040/ -0.016); p < .001

0.044 (0.031/ 0.056); p < .001

− 0.039 (− 0.053/ -0.024); p < .001

0.019 (0.010/ 0.029); p < .001

0.042 (0.031/ 0.053); p < .001

− 0.007 (− 0.016/ 0.001); p = .094

0.048 (0.039/ 0.057); p < .001

0.005 (− 0.025/ -0.005); p = .004

0.011 (−0.006/ 0.028); p = .219

0.040 (0.020/ 0.059); p < .001

− 0.051 (− 0.066/ -0.036); p < .001

0.008 (− 0.007/ 0.024); p = .296

− 0.065 (− 0.083/ -0.046); p < .001

Model 2

High triglycerides

Low HDL

Hypertension

Central obesity

High fasting blood glucose

0.026 (0.011/ 0.040); p < .001

0.033 (0.017/ 0.049); p < .001

− 0.008 (− 0.022/ 0.005); p = .211

0.035 (0.022/ 0.048); p < .001

− 0.022 (− 0.037/ -0.007); p = .003

0.017 (0.007/ 0.028); p = .001

0.027 (0.016/ 0.038); p < .001

0.002 (− 0.008/ 0.011); p = .739

0.038 (0.028/ 0.047); p < .001

− 0.009 (− 0.019/ 0.002); p = .117

0.028 (0.009/ 0.047); p = .004

0.028 (0.007/ 0.048); p = .009

− 0.021 (− 0.038/ -0.003); p = .019

0.008 (− 0.010/ 0.025); p = .385

− 0.039 (− 0.058/ -0.019); p < .001

Model 3

High triglycerides

Low HDL

Hypertension

Central obesity

High fasting blood glucose

0.019 (0.006/ 0.032); p = .005

0.020 (0.005/ 0.034); p = .008

− 0.012 (− 0.025/ 0.000); p = .043

0.024 (0.013/ 0.036); p < .001

− 0.020 (− 0.034/ -0.006); p = .004

0.013 (0.003/ 0.023); p = .011

0.017 (0.007/ 0.028); p = .002

0.000 (− 0.009/ 0.009); p = .985

0.031 (0.022/ 0.040); p < .001

− 0.008 (− 0.018/ 0.002); p = .128

0.020 (0.002/ 0.038); p = .026

0.014 (− 0.005/ 0.033); p = .155

− 0.028 (− 0.044/ -0.012); p = .001

− 0.004 (− 0.020/ 0.012); p = .611

− 0.036 (− 0.054/ -0.018); p < .001

Model 4

High triglycerides

Low HDL

Hypertension

Central obesity

High fasting blood glucose

 

0.008 (−0.001/ 0.016); p = .090

0.012 (0.003/ 0.022); p = .010

0.007 (− 0.001/ 0.015); p = .080

0.031 (0.024/ 0.039); p < .001

0.000 (− 0.009/ 0.009); p = 1.000

0.009 (− 0.007/ 0.024); p = .267

− 0.002 (− 0.019/ 0.015); p = .810

− 0.029 (− 0.043/ -0.015); p < .001

− 0.030 (− 0.044/ -0.017); p < .001

− 0.029 (− 0.045/ -0.013); p < .001

  1. Model 1: without adjustment; Model 2: adjusted for age, sex and socioeconomic status (SES); Model 3: additionally adjusted for somatic conditions (CHD, atrial fibrillation, cancer, myocardial infarction, stroke, PAOD), any anxiety, and psychotropic medication; Model 4: additionally adjusted for cognitive-affective symptoms (dependent variable: somatic-affective symptoms), respectively for somatic-affective symptoms (dependent variable: cognitive-affective symptoms)
  2. aN ranges between 13.363 and 14.499 because of missing data
Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us